Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses
Journal of Veterinary Science · 2023
DOI: 10.4142/jvs.22326 ↗At a glance
Journal article in Journal of Veterinary Science, 2023. Written by Siriluk Rattanabunyong and 8 co-authors. Institution: Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand. Major MEDLINE topics: Anti-HIV Agents, HIV-1, HIV Infections, Cat Diseases. Cited 2 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Office of the Ministry of Higher Education, Science, Research and Innovation, Kasetsart University Reinventing University Program, Kasetsart University Research and Development Institute.
Abstract (original language)
BACKGROUND: Feline immunodeficiency virus (FIV) causes an acquired immunodeficiency-like syndrome in cats. FIV is latent. No effective treatment has been developed for treatment the infected cats. The first and second generations non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV treatment, nevirapine (NVP) and efavirenz (EFV), and rilpivirine (RPV), were used to investigate the potential of NNRTIs for treatment of FIV infection. OBJECTIVE: This study aims to use experimental and in silico approaches to investigate the potential of NNRTIs, NVP, EFV, and RPV, for inhibition of FIV reverse transcriptase (FIV-RT). METHODS: The FIV-RT and human immunodeficiency virus reverse transcriptase (HIV-RT) were expressed and purified using chromatography approaches. The purified proteins were used to determine the IC50 values with NVP, EFV, and RPV. Surface plasmon resonance (SPR) analysis was used to calculate the binding affinities of NNRTIs to HIV-RT and FIV-RT. The molecular docking and molecular dynamic simulations were used to demonstrate the mechanism of FIV-RT and HIV-RT with first and second generation NNRTI complexes. RESULTS: The IC50 values of NNRTIs NVP, EFV, and RPV against FIV-RT were in comparable ranges to HIV-RT. The SPR analysis showed that NVP, EFV, and RPV could bind to both enzymes. Computational calculation also supports that these NNRTIs can bind with both FIV-RT and HIV-RT. CONCLUSIONS: Our results suggest the first and second generation NNRTIs (NVP, EFV, and RPV) could inhibit both FIV-RT and HIV-RT.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
- Program in Basic Science, Maejo University-Phrae Campus, Phrae 54140, Thailand.
- Department of Physiological Chemistry, Faculty of Chemistry, University of Vienna, Vienna 1090, Austria.
- Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, Kasetsart University, Bangkok 10900, Thailand.
- Institute for Theoretical Chemistry, Faculty of Chemistry, University of Vienna, Vienna 1090, Austria.
- National Electronics and Computer Technology, National Science and Technology Development Agency, Pathumthani 12120, Thailand.
ORCID profiles: Siriluk Rattanabunyong, Khuanjarat Choengpanya, Chonticha Suwattanasophon, Duangnapa Kiriwan, Peter Wolschann, Thomanai Lamtha, Abdul Rajjak Shaikh, Jatuporn Rattanasrisomporn, Kiattawee Choowongkomon
Funding
- Office of the Ministry of Higher Education, Science, Research and Innovation
- Kasetsart University Reinventing University Program
- Kasetsart University Research and Development Institute
Cite
APA
Rattanabunyong, S., Choengpanya, K., Suwattanasophon, C., Kiriwan, D., Wolschann, P., Lamtha, T., Shaikh, A. R., Rattanasrisomporn, J., & Choowongkomon, K. (2023). Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses. Journal of Veterinary Science. https://doi.org/10.4142/jvs.22326
Vancouver
Rattanabunyong S, Choengpanya K, Suwattanasophon C, Kiriwan D, Wolschann P, Lamtha T, et al. Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses. Journal of Veterinary Science. 2023. doi:10.4142/jvs.22326
BibTeX
@article{Rattanabunyong2023,
author = {Rattanabunyong, Siriluk and Choengpanya, Khuanjarat and Suwattanasophon, Chonticha and Kiriwan, Duangnapa and Wolschann, Peter and Lamtha, Thomanai and Shaikh, Abdul Rajjak and Rattanasrisomporn, Jatuporn and Choowongkomon, Kiattawee},
title = {Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses},
journal = {Journal of Veterinary Science},
year = {2023},
doi = {10.4142/jvs.22326}
}
EUVIMED